CD80 and ovarian carcinoma: In ovarian cancer cell lines and in ovarian cancer tissues, it was reported that the expression of miR-424 negatively correlated to the expression of CTLA-4/CD80 and PD-L1, and that the restoration of miR-424 re-established T cells activity, reverted chemoresistance and increased free survival time [90].